Imaging patients is more costly when they move.
Patient motion during MR imaging results in added costs to radiology departments, according to a study published in the Journal of the American College of Radiology.
Researchers from the University of Washington and Harborview Medical Center in Seattle, performed a retrospective study to assess the prevalence, severity, and cost estimates associated with motion artifacts identified on clinical MR examinations.
The data were taken from a randomly selected full calendar week in April 2014 of MR images taken on three different scanners. The images were performed across a broad patient population with a wide range of illnesses. The authors noted that not all failed examinations were submitted to PACS, however they were available for review directly on the MR console.
Two blinded radiologists reviewed the data, using a scale of none to severe for clinical quantification of motion artifacts. Costs were calculated based on imaging time and the need for repeat imaging. A total of 192 completed clinical examinations were included in the study. The patients ranged in age from 21 to 87 with a mean age of 56; 97 were women, 95 men. One hundred eighteen image sequences were performed on outpatients, 76 on inpatients or through the emergency department. There were 68 repeat sequences in 38 patients. These took an average of 4 minutes, 10 seconds extra for each sequence, resulting in an added 278.5 minutes of additional scan time.
The results showed there were significant motion artifacts in 7.5% of the outpatient and 29.4% of inpatient and/or emergency department MR examinations. “The prevalence of repeat sequences was 19.8% of total MRI examinations,” the authors wrote. “The base-case cost estimate yielded a potential cost to the hospital of $592 per hour in lost revenue due to motion artifacts. Potential institutional average costs borne (revenue forgone) of approximately $115,000 per scanner per year may affect hospitals, owing to motion artifacts (univariate sensitivity analysis suggested a lower bound of $92,600, and an upper bound of $139,000).”
The researchers concluded that patient motion was a frequent cause of degradation of MR images, which added to substantial costs to the radiology department.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.